title: Follow-up in melanoma patients.
abstract: Due to lack of evidence from prospective clinical trials, the diagnostic procedures, their frequency, as well as the length of the follow-up period in cutaneous melanoma patients should be based on the individual risk of disease recurrence, which is strongly dependent on the stage of disease at the time of diagnosis. In the paper we propose the current recommendations for follow-up strategy. Nowadays, new effective treatment options with biological agents justify the closer monitoring of high risk melanoma patients.
authors.affiliation: Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
authors.forename: Piotr
authors.initials: P
authors.lastname: Rutkowski
authors.affiliation: Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
authors.forename: Iwona
authors.initials: I
authors.lastname: Lugowska
keywords: Follow-up; Melanoma; Recurrences
references.citation: Br J Surg. 2008 Nov;95(11):1401-7
references.pmid: 18844268
references.citation: Ann Surg Oncol. 2010 Jan;17(1):129-37
references.pmid: 19866238
references.citation: Ann Oncol. 2012 Oct;23 Suppl 7:vii86-91
references.pmid: 22997461
references.citation: Ann Surg Oncol. 2007 Jun;14(6):1924-33
references.pmid: 17357855
references.citation: Surg Oncol Clin N Am. 2011 Jan;20(1):181-200
references.pmid: 21111966
references.citation: Arch Dermatol. 2004 Jan;140(1):107-13
references.pmid: 14732667
references.citation: Lancet Oncol. 2005 Aug;6(8):608-21
references.pmid: 16054572
references.citation: Ann Surg. 2014 Jun;259(6):1215-22
references.pmid: 24096759
references.citation: Ann Surg Oncol. 2014 Sep;21(9):3117-23
references.pmid: 24833100
references.citation: JAMA. 1995 Dec 6;274(21):1703-5
references.pmid: 7474276
references.citation: J Clin Oncol. 2003 Feb 1;21(3):520-9
references.pmid: 12560444
references.citation: Melanoma Res. 2011 Oct;21(5):457-63
references.pmid: 21730878
references.citation: Ann Surg Oncol. 2009 Mar;16(3):571-7
references.pmid: 19030934
references.citation: J Clin Oncol. 2011 Dec 10;29(35):4641-6
references.pmid: 22067399
references.citation: J Clin Oncol. 2003 Oct 1;21(19):3707; author reply 3707-8
references.pmid: 14512409
references.citation: J Dtsch Dermatol Ges. 2013 Aug;11 Suppl 6:1-116, 1-126
references.pmid: 24028775
references.citation: N Engl J Med. 2006 Sep 28;355(13):1307-17
references.pmid: 17005948
references.citation: Br J Dermatol. 2008 Aug;159(2):337-41
references.pmid: 18510665
references.citation: Clin Dermatol. 2010 May-Jun;28(3):275-80
references.pmid: 20541679
references.citation: J Surg Oncol. 2013 Apr;107(5):463-8
references.pmid: 23090908
references.citation: Arch Dermatol. 2004 Jan;140(1):67-70
references.pmid: 14732662
references.citation: Melanoma Res. 2007 Dec;17(6):393-9
references.pmid: 17992123
references.citation: Eur J Cancer. 2014 Feb;50(3):602-10
references.pmid: 24262585
references.citation: Ann Surg Oncol. 2009 Apr;16(4):804-5
references.pmid: 19189190
references.citation: Ann Surg Oncol. 2009 Apr;16(4):941-7
references.pmid: 19101766
references.citation: Cancer. 2001 Jun 15;91(12):2409-16
references.pmid: 11413532
references.citation: J Clin Oncol. 2010 Jun 20;28(18):3042-7
references.pmid: 20479405
references.citation: Ann Surg Oncol. 2014 Mar;21(3):752-7
references.pmid: 24114053
references.citation: Semin Oncol. 2003 Jun;30(3):369-74
references.pmid: 12870138
references.citation: Lancet Oncol. 2004 Nov;5(11):673-80
references.pmid: 15522655